ImmuneOncia Therapeutics Hosts Investor Briefing on R&D Progress
ImmuneOncia Therapeutics will host an investor relations briefing in Seoul on Oct. 22, 2026. The in-person event runs from 2 p.m. to 5 p.m. local time for domestic institutional investors and securities analysts. Presentations will cover business operations and pipeline research progress, followed by a question-and-ans